These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36931064)

  • 1. Lexical Characteristics of the Speech Intelligibility Test: Effects on Transcription Intelligibility for Speakers With Multiple Sclerosis and Parkinson's Disease.
    Stipancic KL; Wilding G; Tjaden K
    J Speech Lang Hear Res; 2023 Aug; 66(8S):3115-3131. PubMed ID: 36931064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally Detectable Change of Speech Intelligibility in Speakers With Multiple Sclerosis and Parkinson's Disease.
    Stipancic KL; Tjaden K
    J Speech Lang Hear Res; 2022 May; 65(5):1858-1866. PubMed ID: 35442761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between F2 Slope and Intelligibility in Parkinson's Disease: Lexical Effects and Listening Environment.
    Chiu YF; Forrest K; Loux T
    Am J Speech Lang Pathol; 2019 Jul; 28(2S):887-894. PubMed ID: 31306601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptual measures of speech from individuals with Parkinson's disease and multiple sclerosis: intelligibility and beyond.
    Sussman JE; Tjaden K
    J Speech Lang Hear Res; 2012 Aug; 55(4):1208-19. PubMed ID: 22232396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acoustic characteristics in relation to intelligibility reduction in noise for speakers with Parkinson's disease.
    Chiu Y; Neel A; Loux T
    Clin Linguist Phon; 2021 Mar; 35(3):222-236. PubMed ID: 32539544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear Speech Variants: An Investigation of Intelligibility and Speaker Effort in Speakers With Parkinson's Disease.
    Stipancic KL; van Brenk F; Kain A; Wilding G; Tjaden K
    Am J Speech Lang Pathol; 2022 Nov; 31(6):2789-2805. PubMed ID: 36327495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acoustic and perceptual correlates of faster-than-habitual speech produced by speakers with Parkinson's disease and multiple sclerosis.
    Kuo C; Tjaden K; Sussman JE
    J Commun Disord; 2014; 52():156-69. PubMed ID: 25287378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Lexical Characteristics and Noise on Intelligibility of Parkinsonian Speech.
    Chiu YF; Forrest K
    J Speech Lang Hear Res; 2018 Apr; 61(4):837-846. PubMed ID: 29587306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating Acoustic Correlates of Intelligibility Gains and Losses During Slowed Speech: A Hybridization Approach.
    van Brenk F; Kain A; Tjaden K
    Am J Speech Lang Pathol; 2021 Jun; 30(3S):1343-1360. PubMed ID: 34048663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Picture Description in the Assessment of Connected Speech Intelligibility in Parkinson's Disease: A Pilot Study.
    Johansson IL; Samuelsson C; Müller N
    Folia Phoniatr Logop; 2022; 74(5):320-334. PubMed ID: 35021169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consonant articulation acoustics and intelligibility in Swedish speakers with Parkinson's disease: a pilot study.
    Johansson IL; Samuelsson C; Müller N
    Clin Linguist Phon; 2023 Sep; 37(9):845-865. PubMed ID: 35833475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis.
    Tjaden K; Sussman JE; Wilding GE
    J Speech Lang Hear Res; 2014 Jun; 57(3):779-92. PubMed ID: 24687042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between acoustic measures and judgments of intelligibility in Parkinson's disease: a within-speaker approach.
    Feenaughty L; Tjaden K; Sussman J
    Clin Linguist Phon; 2014 Nov; 28(11):857-78. PubMed ID: 24874184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Interaction of Lexical Characteristics and Speech Production in Parkinson's Disease.
    Chiu YF; Forrest K
    J Speech Lang Hear Res; 2017 Jan; 60(1):13-23. PubMed ID: 28056148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybridizing conversational and clear speech to investigate the source of increased intelligibility in speakers with Parkinson's disease.
    Tjaden K; Kain A; Lam J
    J Speech Lang Hear Res; 2014 Aug; 57(4):1191-205. PubMed ID: 24686409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Lexical and Articulatory Factors in the Automatic Selection of Test Materials for a Web-Based Assessment of Intelligibility in Dysarthria.
    Lehner K; Ziegler W
    J Speech Lang Hear Res; 2021 Jun; 64(6S):2196-2212. PubMed ID: 33647214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contextual effects in the measurement of hearing-impaired speakers' intelligibility.
    Sitler RW; Schiavetti N; Metz DE
    J Speech Hear Res; 1983 Mar; 26(1):30-5. PubMed ID: 6865378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cross-Language Study of Acoustic Predictors of Speech Intelligibility in Individuals With Parkinson's Disease.
    Kim Y; Choi Y
    J Speech Lang Hear Res; 2017 Sep; 60(9):2506-2518. PubMed ID: 28821018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acoustic and intelligibility characteristics of sentence production in neurogenic speech disorders.
    Weismer G; Jeng JY; Laures JS; Kent RD; Kent JF
    Folia Phoniatr Logop; 2001; 53(1):1-18. PubMed ID: 11125256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease and the effect of lexical factors on vowel articulation.
    Watson PJ; Munson B
    J Acoust Soc Am; 2008 Nov; 124(5):EL291-5. PubMed ID: 19045680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.